PTSD

Revitalist CEO Kathryn Walker Explains Bold Plans For Expansion: 120 Clinics by 2023

Sep 15, 2021

MDMA for Traumatic Brain Injury? Wesana Health And MAPS To Assess Drug’s Treatment Viability

Sep 15, 2021

Seattle Is On Track To Be The Next U.S. City To Decriminalize Psychedelics

Sep 14, 2021

Numinus Inc. CEO Payton Nyquvest Answers Your Reader-Submitted Questions

Sep 10, 2021

Numinus Maps Out Cure For PTSD With Open Label Study

Aug 9, 2021

Ocasio-Cortez Re-Submits Amendment in Favor of Psychedelic Research

Jul 26, 2021

Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds

Jul 21, 2021

MDMA For PTSD: Health Canada Approves Numinus’ MAPS-Sponsored Study

Jul 16, 2021

Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD

Jul 12, 2021

Mydecine CEO Josh Bartch Speaks on Psilocybin and Smoking Cessation

Jul 8, 2021